Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
TSL1502
i
Other names:
TSL1502, TSL-1502, TSL 1502
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Tasly
Drug class:
PARP inhibitor
Related drugs:
‹
olaparib (342)
talazoparib (81)
niraparib (80)
rucaparib (71)
ABT-888 (35)
pamiparib (18)
fluzoparib (12)
JPI-547 (7)
IMP4297 (6)
NOV 1401 (3)
SC10914 (2)
ABT-767 (1)
SBP-101 (1)
AMXI-5001 (0)
AZD2461 (0)
E7016 (0)
HWH340 (0)
MK-4837 (0)
[²¹¹At]PTT (0)
kt-3283 (0)
SMOCL-9112 (0)
2X-121 (0)
olaparib (342)
talazoparib (81)
niraparib (80)
rucaparib (71)
ABT-888 (35)
pamiparib (18)
fluzoparib (12)
JPI-547 (7)
IMP4297 (6)
NOV 1401 (3)
SC10914 (2)
ABT-767 (1)
SBP-101 (1)
AMXI-5001 (0)
AZD2461 (0)
E7016 (0)
HWH340 (0)
MK-4837 (0)
[²¹¹At]PTT (0)
kt-3283 (0)
SMOCL-9112 (0)
2X-121 (0)
›
Associations
News
Trials
Filter by
Latest
8ms
A Study to Evaluate the Efficacy and Safety of TSL-1502 Capsules in Breast Cancer Patients With Germline BRCA Mutations (clinicaltrials.gov)
P2, N=125, Recruiting, Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. | Not yet recruiting --> Recruiting
8 months ago
Enrollment open • Metastases
|
HER-2 (Human epidermal growth factor receptor 2) • BRCA (Breast cancer early onset)
|
HR positive
|
capecitabine • Halaven (eribulin mesylate) • TSL1502
over2years
A Study to Evaluate the Efficacy and Safety of TSL-1502 Capsules in Breast Cancer Patients With Germline BRCA Mutations (clinicaltrials.gov)
P2, N=125, Not yet recruiting, Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.
over 2 years ago
New P2 trial
|
HER-2 (Human epidermal growth factor receptor 2) • BRCA (Breast cancer early onset)
|
HR positive
|
capecitabine • Halaven (eribulin mesylate) • TSL1502
Share via
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login